The number of young women presenting with STEMI is increasing worldwide, and they face a particularly worrisome risk of mortality due to under-diagnosis and treatment delay, according to a EuroPCR conference session led by Drs. Alaide Chieffo and Josepa Mauri, members of SCAI's Women in Innovations initiative who have spent years calling attention to the issue. The causes of STEMI in women may differ from those in men, calling for a range of diagnostic tools. "We want to take the time to remind interventionalists that this is an urgent issue," Mauri said. "This is a question of saving lives."
Published in Brief: